Cambridge, MA, January 4, 2023 (Proactive Investors) -- Moderna Inc, the biotech pioneering messenger RNA (mRNA) therapeutics and vaccines, said it has struck a deal to buy Japan-based OriCiro Genomics for US$85 million to boost its manufacturing capabilities.
Read full article here.
South San Francisco, CA, November 18, 2024 (Globe Newswire) -- Zenflow, Inc., a leader in medical device innovation for urological...
Philadelphia, November 14, 2024 (PRNewswire) -- Nobias Therapeutics has named Patrick Dougherty as its Chief Executive Officer, marking...
New York, November 13, 2024 (Business Wire) -- Metsera has raised $215 million in Series B financing, led by Wellington Management and...
Comments